This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: American Diagnostica, Inc., Quebepharma Recherche, Inc.. Active years: 2004-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 7 
1 out of 2 Years Active: 2004-2010
Title: Seong Soo A An: Innovator in Thrombin-Activatable Fibrinolysis Inhibitor Research
Introduction
Seong Soo A An is a notable inventor based in Hopewell Junction, NY (US). He has made significant contributions to the field of medical research, particularly in the area of thrombin-activatable fibrinolysis inhibitors. With a total of 4 patents to his name, An's work has the potential to impact various therapeutic applications.
Latest Patents
An's latest patents focus on methods of screening for compounds that modulate TAFIa activity. These patents provide innovative methods for screening compounds related to aspirin activity, specifically targeting non-inhibition of TAFI. The compounds identified through these methods can be utilized to treat, prevent, or manage conditions such as pain, fever, colon cancer, pancreatic cancer, and various inflammatory diseases. Additionally, his patents include methods for evaluating test compounds for TAFI inhibitory activity, comparing them to aspirin or its derivatives. An's work also contemplates methods for managing hemorrhagic or thrombotic diseases using high doses of aspirin or its derivatives, along with factors that promote TAFIa activity to mitigate adverse side effects.
Career Highlights
Throughout his career, Seong Soo A An has worked with reputable companies such as American Diagnostica, Inc. and Quebepharma Recherche, Inc. His experience in these organizations has contributed to his expertise in the field of medical diagnostics and therapeutic development.
Collaborations
An has collaborated with various professionals in his field, including his coworker Jean Vaugeois. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in medical science.
Conclusion
Seong Soo A An is a distinguished inventor whose work in thrombin-activatable fibrinolysis inhibitors has the potential to revolutionize treatment options for various medical conditions. His contributions to the field are marked by his innovative patents and collaborations, showcasing his commitment to advancing medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile